ABWM
GILD icon

Alpine Bank Wealth Management’s Gilead Sciences GILD Stock Holding History

Alpine Bank Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-639
Closed -$70.9K – 256
2025
Q3 		$70.9K Buy
639
+25
+4% +$2.84K 0.01% 221
2025
Q2 		$68.1K Hold
614
– – 0.01% 222
2025
Q1 		$68.8K Buy
+614
New +$63.4K 0.01% 209
2024
Q3 		$85.1K Buy
+1,015
New +$77.4K 0.01% 201

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Alpine Bank Wealth Management's GILD Position: Q4 2025 in Review

Alpine Bank Wealth Management sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 639 shares — an estimated $70.9K sold.

Alpine Bank Wealth Management first reported a position in GILD in Q3 2024 and held it in 4 quarters. The position peaked at $85.1K in Q3 2024. 2,216 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Alpine Bank Wealth Management reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Alpine Bank Wealth Management sold 639 Gilead Sciences shares in Q4 2025, an estimated $70.9K.
  • Alpine Bank Wealth Management first reported a position in Gilead Sciences in Q3 2024 and held it in 4 quarters.
  • Alpine Bank Wealth Management's Gilead Sciences position peaked at $85.1K in Q3 2024.
  • 2,216 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Alpine Bank Wealth Management's 13F filing for Q4 2025, filed 15 Jan 2026.